EXPANDING THE DOCTRINE OF INNOVATOR LIABILITY: USING TORT LIABILITY TO CREATE A VIABLE FOLLOW-ON BIOLOGIC REGIME Prachi V. Mehta*

Source URL: illinoisjltp.com

• Tort law
• Drug Price Competition and Patent Term Restoration Act
• Generic drug
• Tort
• Food and Drug Administration
• Biosimilar
• Abbreviated New Drug Application
• Product liability
• Pharmaceutical industry
• Pharmaceutical sciences
• Pharmacology
• Clinical research

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NICE’s biosimilars position statement NICE’s approach on biosimilars is: a. NICE will consider similar biological medicinal products notified to it by the National

Source URL: www.nice.org.uk

• Medicine
• Clinical research
• Biologic
• Health
• National Institute for Health and Clinical Excellence
• Nice
• Biosimilar
• Biotechnology
• Drugs

Biosimilar medicines – NICE’s approach A biological medicine is any medicinal product made by or derived from a biological (natural) source, for example, an animal cell or microorganism. The first biological medicine

Source URL: www.nice.org.uk

• Biotechnology
• Drugs
• Medicine
• Pharmaceutical sciences
• Biologic
• National Institute for Health and Clinical Excellence
• Pharmaceutical drug
• Pharmacology
• Clinical research
• Biosimilar

The Use of Human Biobanks – Ethical, Social, Economical and Legal Aspects Prohibitions against the transfer of human tissue and cells for profit1 Bengt Domeij Industrial Economy and Organization, Royal Institute of Te

Source URL: www.crb.uu.se

• Health
• Biologic
• Transplantation medicine
• Medical ethics
• Human Tissue Authority
• Medicine
• Biology
• Biobank

School of Science - Undergraduate Minor Program in Biotechnology (For all students in the Program) Undergraduate Minor Program in Biotechnology Except for those with major in Biochemistry and Cell Biology (BCB), Biologic

Source URL: ugadmin.ust.hk

PIDS Headquarters 1300 Wilson Boulevard, Suite 300 Arlington, VA[removed]Tel: ([removed]Fax: ([removed]removed]

Source URL: www.pids.org

• Pharmacology
• Research
• Clinical research
• Pharmaceutical industry
• Center for Biologics Evaluation and Research
• Biologic
• Clinical trial
• Investigational New Drug
• Center for Devices and Radiological Health
• Food and Drug Administration
• Medicine
• Health

Post-market review of authority required PBS listings Joint Submission from Arthritis Australia and the Australian Rheumatology Association About Arthritis Australia Arthritis Australia is the peak arthritis organisation

Source URL: pbs.gov.au

• Arthritis
• Rheumatology
• Connective tissue diseases
• Aging-associated diseases
• Rheumatoid arthritis
• Medical prescription
• Biologic
• Pharmaceutical drug
• Health
• Medicine
• Pharmacology

Biosimilars Naming Letter

Source URL: www.rheumatology.org

• Anatomy
• Cutaneous lupus erythematosus
• Systemic lupus erythematosus
• Biosimilar
• Biologic
• Lupus Foundation of America
• Food and Drug Administration
• Rheumatology
• Autoimmunity
• Medicine
• Health
• Pharmacology

August 14, 2014 The Honorable Margaret A. Hamburg, M.D. Commissioner U.S. Food and Drug Administration[removed]New Hampshire Avenue Silver Spring, MD 20993

Source URL: www.rheumatology.org

• Rheumatology
• Specialty
• Clinical research
• Education
• Medicine
• Biologic
• Pharmacology
• Biosimilar

July 31, 2014 The Honorable Dave Camp Chairman Committee on Ways and Means United States House of Representatives 341 Cannon House Office Building

Source URL: www.rheumatology.org

• Healthcare reform in the United States
• Presidency of Lyndon B. Johnson
• Medicine
• Clinical research
• Biologic
• Rheumatoid arthritis
• Medicare
• Rheumatology
• Food and Drug Administration
• Health
• Pharmacology
• Federal assistance in the United States